↓ Skip to main content

The xc− cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, December 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

patent
20 patents

Citations

dimensions_citation
107 Dimensions

Readers on

mendeley
71 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The xc− cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine
Published in
Cancer Chemotherapy and Pharmacology, December 2008
DOI 10.1007/s00280-008-0894-4
Pubmed ID
Authors

Jun Guan, Maisie Lo, Peter Dockery, Sarah Mahon, Cristina M. Karp, Arthur R. Buckley, Stephen Lam, Peter W. Gout, Yu-Zhuo Wang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ireland 1 1%
Unknown 70 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 20%
Student > Master 10 14%
Student > Ph. D. Student 7 10%
Student > Bachelor 6 8%
Other 4 6%
Other 9 13%
Unknown 21 30%
Readers by discipline Count As %
Agricultural and Biological Sciences 14 20%
Biochemistry, Genetics and Molecular Biology 13 18%
Medicine and Dentistry 9 13%
Pharmacology, Toxicology and Pharmaceutical Science 6 8%
Chemistry 2 3%
Other 6 8%
Unknown 21 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 February 2023.
All research outputs
#3,465,367
of 23,815,455 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#118
of 2,501 outputs
Outputs of similar age
#17,055
of 173,176 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#1
of 20 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,501 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,176 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.